Rest Of Europe Digital Therapeutics/DTx Market (2026-2031)
The Rest Of Europe Digital Therapeutics/DTx Market was valued at $403.2 Million in 2026 and projected to reach to $1151.4 Million by 2031, representing a compound annual growth rate of 23.4%. Rest Of Europe's Digital Therapeutics market is positioned for exceptional growth through 2031, driven by healthcare system modernization initiatives and rising demand for cost-effective treatment alternatives.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
Rest Of Europe Digital Therapeutics/DTx Market Trends and Insights
- This 23.4% compound annual growth rate reflects Rest Of Europe's increasing adoption of digital health solutions and regulatory support for DTx innovations.
- Rest Of Europe is positioning itself as a key growth region, driven by healthcare digitalization initiatives and rising demand for remote patient monitoring solutions. The Rest Of Europe DTx market benefits from a diverse healthcare landscape and growing investment in digital health infrastructure.
- Rest Of Europe's regulatory frameworks are becoming increasingly favorable for DTx approval and reimbursement, accelerating market penetration across multiple therapeutic areas.
- Rest Of Europe's healthcare systems are prioritizing cost-effective treatment alternatives, making digital therapeutics an attractive option for both providers and payers throughout the forecast period..
Key Market Statistics
- CAGR (2026-2031) 23.4% CAGR
- Market Size, 2026 ~USD 403.2 Million
- Forecast, 2031 ~USD 1151.4 Million
- Country Rest Of Europe
Rest Of Europe Digital Therapeutics/DTx Market Overview
Strong CAGR Growth :
Rest Of Europe's Digital Therapeutics market is expanding at 23.4% CAGR, demonstrating robust investor confidence and accelerating adoption of DTx solutions across the region's healthcare systems.
Significant Market Expansion :
Market valuation is projected to nearly triple from $403.2 million in 2026 to $1,151.4 million by 2031, reflecting Rest Of Europe's commitment to digital health innovation and modernization.
Regulatory Support Framework :
Rest Of Europe benefits from progressive regulatory environments and government initiatives supporting DTx innovations, creating favorable conditions for market penetration and product launches.
Healthcare Digitalization Momentum :
Increasing adoption of digital health solutions across Rest Of Europe's healthcare systems is driving demand for evidence-based Digital Therapeutics to address chronic disease management and patient outcomes.
Rest Of Europe Digital Therapeutics/DTx Market Dynamics
- The region's regulatory bodies are increasingly supportive of DTx innovations, enabling faster market entry and reimbursement pathways.
- Healthcare providers are actively integrating digital therapeutics into clinical workflows to improve patient engagement and treatment adherence. The market expansion is further supported by growing healthcare expenditures, aging populations requiring chronic disease management, and digital health infrastructure investments across Rest Of Europe.
- Partnerships between technology companies and healthcare institutions are accelerating DTx adoption, while patient awareness of digital health solutions continues to rise.
- This convergence of factors positions Rest Of Europe as a critical growth market within the global Digital Therapeutics landscape..
Market Ecosystem
DIGITAL THERAPEUTICS MARKET: COMMERCIAL USE CASES ACROSS INDUSTRIES
| COMPANY | USE CASE DESCRIPTION | BENEFITS |
|---|---|---|
 |
AI-enabled virtual care, chronic disease management, remote patient monitoring (RPM), and integrated digital therapeutics platform | Improved patient engagement, reduced hospitalizations, enhanced chronic disease outcomes, and expanded access to virtual care |
 |
AI-powered behavior change platform, digital weight management, nutrition coaching, and personalized lifestyle interventions | Sustainable weight loss, improved metabolic health, higher patient adherence, and reduced risk of chronic diseases |
 |
AI-driven musculoskeletal (MSK) digital therapy, wearable-enabled motion tracking, computer vision, and virtual physical therapy | Faster recovery, reduced pain, lower musculoskeletal treatment costs, and decreased need for surgery or opioid use |
 |
Digital chronic disease prevention and management platform for diabetes, hypertension, obesity, and cardiovascular health using connected devices and personalized coaching | Improved clinical outcomes, better disease control, increased medication adherence, and reduced healthcare expenditures |
 |
AI-powered digital therapeutics platform integrating glucose monitoring, blood pressure monitoring, behavioral health, and personalized coaching | Better disease self-management, improved patient outcomes, enhanced engagement, and lower total cost of care |
Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.
Related Ecosystem
Healthcare Analytics
- Machine Learning
- Natural Language Processing (NLP)
- Blood Pressure Monitors
- Computed Tomography (CT)
- Magnetic Resonance Imaging (MRI)
- Oracle Corporation
- PHILIPS HEALTHCARE
- Siemens healthineers
- Zensar Technologies Limited
- EPIC SYSTEMS CORPORATION
Healthcare It
- Computed Tomography (CT)
- Machine Learning
- Magnetic Resonance Imaging (MRI)
- Natural Language Processing (NLP)
- Predictive Analytics
- CERNER CORPORATION
- PHILIPS HEALTHCARE
- Oracle Corporation
- GE HealthCare Technologies Inc.
- Siemens healthineers
Key Takeaways
- Rest Of Europe's DTx market will nearly triple from $403.2M (2026) to $1,151.4M (2031), representing a 23.4% CAGR.
- Rest Of Europe is experiencing accelerated regulatory approval pathways and reimbursement policies favoring digital therapeutic adoption.
- Rest Of Europe's healthcare systems are increasingly integrating DTx solutions for chronic disease management and mental health applications.
- Rest Of Europe's market growth is driven by digital health infrastructure investments and rising demand for remote patient monitoring capabilities.
Digital Therapeutics/DTx Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2026 |
| Fastest Growing Segment | IMMERSIVE & INTERFACE-BASED THERAPEUTICS (Offering) |
| Forecast Period | 2026-2031 |
| Growth Rate | CAGR of 26.4% from 2026 to 2031 |
| Largest Segment | B2B SALES CHANNELS (Sales Channel) |
| Market Size Base Year (Billions) | ~USD 10.96 (2026) |
| Revenue Forecast (Billions) | ~USD 35.37 (2031) |
| Segments Covered | Offering, Product Type, Application, Type, Revenue Model, Sales Channel, End User |
Rest Of Europe Digital Therapeutics/DTx Market Report Segmentation
7 segment dimensions are covered across the global market.
By Offering
- Immersive & Interface-Based Therapeutics
- Software/Platforms
- Therapeutic Programs
By Product Type
- Non-Prescription Digital Therapeutics
- Prescription Digital Therapeutics
By Application
- Preventive Applications
- Treatment & Care-Related Applications
By Type
- Cardiovascular Diseases
- Central Nervous System (Cns) Disorders
- Chronic Respiratory Diseases
- Diabetes
- Diagnostic & Rehabilitation Centers
- Hospitals
- Medication Adherence
- Musculoskeletal Disorders
- Nutrition & Lifestyle Management
- Obesity & Weight Management
- Other Healthcare Providers
- Other Preventive Applications
- Other Treatment & Care-Related Applications
- Prediabetes
- Private Payers
- Public Payers
- Rehabilitation & Patient Care
- Sleep Disorders
- Smoking Cessation
- Specialty Clinics
- Substance Use Disorders & Addiction Management
By Revenue Model
- Licensing (Enterprise/SaaS) Models
- Outcome-/Value-Based Models
- Subscription-Based Models
By Sales Channel
- B2B Sales Channels
- B2C Sales Channels
By End User
- Employers
- Healthcare Payers
- Healthcare Providers
- Other End Users
- Patients/Individuals
Target Audience
- DTx Companies & Startups : Need Rest Of Europe-specific market data to validate expansion strategies, identify regulatory requirements, and develop localized commercialization plans for digital therapeutic products.
- Healthcare Providers & Institutions : Require insights into DTx adoption trends, clinical efficacy data, and integration strategies to enhance patient outcomes and operational efficiency within Rest Of Europe's healthcare systems.
- Investment & Venture Capital Firms : Seek comprehensive market intelligence on Rest Of Europe's DTx growth potential, competitive landscape, and investment opportunities to guide funding decisions and portfolio development.
- Pharmaceutical & Medtech Companies : Need Rest Of Europe market analysis to evaluate DTx partnerships, licensing opportunities, and strategic positioning within the region's evolving digital health ecosystem.
- Healthcare Policy & Government Bodies : Require market data to inform regulatory frameworks, reimbursement policies, and digital health initiatives supporting DTx innovation and accessibility across Rest Of Europe.
Reasons to Buy this Report
- Market Size & Growth Validation : Comprehensive data validating Rest Of Europe's DTx market expansion from $403.2M to $1,151.4M, enabling accurate business planning and investment decisions specific to this high-growth region.
- Competitive Landscape Intelligence : Detailed insights into Rest Of Europe's competitive dynamics, regulatory environment, and market entry strategies essential for companies targeting this region's unique healthcare infrastructure.
- Regional Opportunity Identification : Identify high-potential DTx segments and therapeutic areas within Rest Of Europe, enabling targeted product development and go-to-market strategies aligned with regional healthcare priorities.
- Investment & Partnership Strategy : Data-driven insights supporting investment decisions, partnership opportunities, and M&A strategies within Rest Of Europe's rapidly expanding Digital Therapeutics ecosystem.
- Regulatory & Reimbursement Pathways : Understanding Rest Of Europe's regulatory frameworks and reimbursement mechanisms critical for successful DTx commercialization and sustainable market penetration across the region.
Frequently asked questions
What is the projected market size for Digital Therapeutics in Rest Of Europe by 2031?
Rest Of Europe's DTx market is projected to reach $1,151.4 million by 2031, growing from $403.2 million in 2026.
What is the CAGR for Rest Of Europe's Digital Therapeutics market?
Rest Of Europe's Digital Therapeutics market is expected to grow at a compound annual growth rate of 23.4% between 2026 and 2031.
Which therapeutic areas are driving growth in Rest Of Europe's DTx market?
Rest Of Europe's DTx market is primarily driven by chronic disease management, mental health applications, and remote patient monitoring solutions.
How are regulatory frameworks supporting DTx adoption in Rest Of Europe?
Rest Of Europe's regulatory bodies are implementing favorable approval pathways and reimbursement policies that accelerate digital therapeutic market penetration.
What factors are contributing to Rest Of Europe's DTx market expansion?
Rest Of Europe's market growth is fueled by healthcare digitalization initiatives, increased investment in digital health infrastructure, and demand for cost-effective treatment alternatives.
RESEARCH METHODOLOGY
This research study involved the extensive use of both primary and secondary sources. It involved the analysis of various factors affecting the industry to identify the segmentation types, industry trends, key players, the competitive landscape of market players, and key market dynamics such as drivers, opportunities, challenges, restraints, and key player strategies.
Secondary Research
This research study extensively utilized secondary sources, including directories, databases such as Dun & Bradstreet, Bloomberg Businessweek, and Factiva, as well as white papers, annual reports, and companies' house documents. The secondary research aimed to gather and analyze information for a comprehensive and commercially focused study of the digital therapeutics market, encompassing technical aspects and market dynamics. It also facilitated the identification of key players, market classification, industry trends, geographical markets, and significant market-related developments. Additionally, a database of prominent industry leaders was compiled through secondary research.
Primary Research
In the primary research process, various supply-side and demand-side sources were interviewed to obtain qualitative and quantitative information for this report. Primary sources from the supply side included industry experts such as CEOs, vice presidents, marketing and sales directors, technology & innovation directors, engineers, and related key executives from various companies and organizations operating in the digital therapeutics market. Primary sources from the demand side included personnel from healthcare providers, payers, employees, and patients/individuals.
Others include sales managers, marketing managers, and product managers.
Note: Tiers are defined based on a company’s total revenue, as of 2025: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = <USD 500 million
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
The total size of the digital therapeutics market was determined after data triangulation through the two approaches mentioned below. After the completion of each approach, the weighted average of these approaches was taken based on the level of assumptions used in each approach.
Global Digital Therapeutics Market Size: Top-down Approach and Bottom-up Approach
Data Triangulation
The size of the digital therapeutics market was estimated through segmental extrapolation using the bottom-up approach. The methodology used is as given below:
- Revenues for individual companies were gathered from public sources and databases.
- Shares of leading players in the digital therapeutics market were gathered from secondary sources to the extent available. In certain cases, shares of digital therapeutics businesses have been ascertained after a detailed analysis of various parameters, including product portfolios, market positioning, selling price, and geographic reach & strength.
- Individual shares or revenue estimates were validated through interviews with experts.
- The total revenue in the digital therapeutics market was determined by extrapolating the market share data of major companies.
Market Definition
The digital therapeutics market comprises evidence-based, clinically validated software solutions designed to prevent, manage, or treat medical conditions through therapeutic interventions delivered via digital technologies. These solutions are delivered through mobile applications, web-based platforms, connected devices, and immersive technologies, and may be prescribed by healthcare professionals or accessed directly by consumers. By leveraging data analytics, artificial intelligence (AI), and personalized behavioral interventions, digital therapeutics improve clinical outcomes, enhance patient engagement, and support the prevention and management of acute and chronic diseases.
Key Stakeholders
- Digital therapeutics developers and platform providers
- Pharmaceutical and biotechnology companies
- Healthcare providers (hospitals, specialty clinics, rehabilitation centers, and primary care centers)
- Health insurance companies (public and private payers)
- Employers and corporate wellness providers
- Medical device and wearable technology companies
- Academic medical centers, universities, and research institutions
- Regulatory agencies and health technology assessment (HTA) bodies
- Government and public health organizations
- Telehealth and digital health platform providers
- Electronic health record (EHR) and healthcare IT solution providers
- Investors, venture capital firms, and private equity firms
- Patients and patient advocacy organizations
- Business research and consulting service providers
Report Objectives
- To define, describe, and forecast the digital therapeutics market based on offering, product type, application, revenue model, sales channel, end user, and region
- To provide detailed information regarding the major factors influencing market growth (such as drivers, restraints, opportunities, and challenges)
- To analyze the micromarkets with respect to individual growth trends, prospects, and contributions to the overall digital therapeutics market
- To analyze the opportunities for stakeholders and provide details of the competitive landscape for market leaders
- To forecast the size of the market segments with respect to five main regions, namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
- To profile the key players and analyze their market shares and core competencies
- To track and analyze competitive developments such as product launches & approvals, partnerships, agreements, and collaborations in the overall digital therapeutics market
- To benchmark players within the market using the proprietary "Competitive Leadership Mapping" framework, which analyzes market players on various parameters within the broad categories of business and product strategy.
Available customizations:
With the given market data, MarketsandMarkets offers customizations as per your company’s specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to 5)
Geographic Analysis
- Further breakdown of the Rest of Asia Pacific digital therapeutics market into Taiwan, New Zealand, Thailand, Singapore, Malaysia, and other countries
- Further breakdown of the Rest of Europe digital therapeutics market into Russia, Austria, Finland, Sweden, Turkey, Norway, Poland, Portugal, Romania, Denmark, and other countries
Get the Full Digital Therapeutics/DTx Market Report
Full forecast, segment splits, and company analysis for all Digital Therapeutics/DTx Market.
- US Digital Therapeutics/DTx Market
- Canada Digital Therapeutics/DTx Market
- Germany Digital Therapeutics/DTx Market
- France Digital Therapeutics/DTx Market
- UK Digital Therapeutics/DTx Market
- Italy Digital Therapeutics/DTx Market
- Spain Digital Therapeutics/DTx Market
- China Digital Therapeutics/DTx Market
- Japan Digital Therapeutics/DTx Market
- India Digital Therapeutics/DTx Market
- Australia Digital Therapeutics/DTx Market
- South Korea Digital Therapeutics/DTx Market
- Brazil Digital Therapeutics/DTx Market
- Mexico Digital Therapeutics/DTx Market
- Saudi Arabia Digital Therapeutics/DTx Market
- UAE Digital Therapeutics/DTx Market
- South Africa Digital Therapeutics/DTx Market
- Rest Of Asia Pacific Digital Therapeutics/DTx Market
- Rest Of Latin America Digital Therapeutics/DTx Market
- GCC Countries Digital Therapeutics/DTx Market
- Rest Of GCC Countries Digital Therapeutics/DTx Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report
